Log inSign up
Pharma-Marketing.comPharma-Marketing.com
  • Industry
  • Digital Health & AI
  • Channels
  • People
  • Agencies
  • Glossary
Log inSign up
  • Terms of Service
  • Privacy Policy
  • Cookie settings
  • Imprint
Pharma-Marketing.com


All rights reserved.

We use AI tools in the creation of certain content.

Pharma Marketing

Data-privacy settings

We use cookies to improve our website and services. They help us understand how visitors use our website. Some cookies are required for the website to function. These are marked as “essential” in the details.

AcceptEssential cookie
NameData-privacy settings
ProviderPharma-Marketing.com
PurposeStores these privacy settings in your browser.
Privacy policyPrivacy policy
Cookiespm_data_privacy
Cookie expiration180 days
Accept
NameGoogle Analytics
ProviderGoogle LLC
PurposeCookies by Google are used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_ga, _gat, _gid
Cookie expiration2 Years
Accept
NameGoogle Ads
ProviderGoogle LLC
PurposeCookies by Google Ads are used for advertising and targeting purpose.
Privacy policyPrivacy policy
Cookies__gsas, __gpi, __gpi_optout, NID, DSID, test_cookie, id, __gads
Cookie expiration2 Years
Accept
NameFacebook
ProviderFacebook Inc.
PurposeCookies by Facebook are used for advertising and marketing activities. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_fbp, fr
Cookie expiration2 Years
Accept
NameMicrosoft Clarity
ProviderMicrosoft Corporation
PurposeCookies by Microsoft Clarity are used for website analytics, heatmaps, and session recordings. They help us understand how visitors interact with our website so we can improve usability and performance.
Privacy policyPrivacy policy
Cookies_clck, _clsk, CLID, ANONCHK, MR, MUID, SM
Cookie expirationUp to 1 Year
© Image: Snapchat

Thursday, August 13, 2026

Snapchat adds multi-CTA ad format for pharma disclosure needs

Snapchat is seeking to make its advertising environment more workable for pharmaceutical brands. The platform has introduced an ad format intended to help branded prescription drug campaigns handle disclosure requirements within social media placements.

The update expands Snapchat’s call-to-action options. Advertisers can now add up to three disclaimer CTAs alongside one primary CTA. In practice, a campaign could direct users to a brand destination while also providing links to safety information, patient materials or prescribing information from the same ad unit.

Broader use across Snapchat formats

Snapchat said the capability is designed to support compliant campaign setups across several of its ad products, including Snap Ads, Story Ads and Commercials. Sponsored Snaps are expected to be supported later in the year. For pharma marketers, the change could reduce format constraints when planning campaigns on the platform.

Disclosure in social media advertising has been a long-running issue for drug marketers, platforms and regulators. Short-form environments create challenges for presenting both benefit and risk information. In 2014, the FDA issued draft guidance addressing how companies could present risk and benefit information on platforms with space limitations. Links to risk information were part of that framework.

Smaller scale than Meta, younger audience

Snapchat reported 493 million daily active users in the second quarter, up 5 percent year over year. That remains far below Meta’s scale. Meta reported 3.6 billion logged-in users across Facebook, Instagram, Messenger and WhatsApp in June.

Snapchat’s appeal for marketers lies partly in its age profile. Most users are between 18 and 34 years old. Pharma campaign announcements more often reference Meta platforms, especially Facebook and Instagram, as well as TikTok. Still, Snapchat has appeared in recent pharma marketing activity, including Eli Lilly’s campaign with WNBA player Caitlin Clark, which included a national platform takeover.

The new ad option signals a more deliberate push by Snapchat toward regulated healthcare advertisers. Adoption by pharma companies will likely depend on whether the added disclaimer CTAs fit brand review processes and compliance expectations.

Advertisement

Only a few physicians log in to your website?

Advertisement

A login that sets a new standard for authenticating HCPs and equips your marketing team with everything they need to successfully promote Rx-products. Learn more on DocID.pro


Stay up to date!

Subscribe to our free Pharma-Marketing-Newsletter.


A Partner For Successful Marketing in Pharma & Healthcare

Advertisement

8awake, the specialized agency for pharma and healthcare marketing, supports you with the successful development and execution of winning campaign activities in healthcare.

Leading providers in pharma and healthcare marketing

Sponsored
  • MINTT Digital
  • 8awake
  • MINTT Digital

  • 8awake

    The leading Healthcare & Pharma-Marketing-Agency

Looking for a new partner in pharma and healthcare marketing?

Visit our agency finder

Copyright 2026 Pharma-Marketing.com.